1. Home
  2. COEP vs SPCB Comparison

COEP vs SPCB Comparison

Compare COEP & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • SPCB
  • Stock Information
  • Founded
  • COEP 2017
  • SPCB 1988
  • Country
  • COEP United States
  • SPCB Israel
  • Employees
  • COEP 7
  • SPCB N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • SPCB Semiconductors
  • Sector
  • COEP Health Care
  • SPCB Technology
  • Exchange
  • COEP Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • COEP 22.3M
  • SPCB 19.2M
  • IPO Year
  • COEP N/A
  • SPCB N/A
  • Fundamental
  • Price
  • COEP $9.27
  • SPCB $13.42
  • Analyst Decision
  • COEP
  • SPCB
  • Analyst Count
  • COEP 0
  • SPCB 0
  • Target Price
  • COEP N/A
  • SPCB N/A
  • AVG Volume (30 Days)
  • COEP 1.0M
  • SPCB 3.0M
  • Earning Date
  • COEP 11-13-2024
  • SPCB 11-14-2024
  • Dividend Yield
  • COEP N/A
  • SPCB N/A
  • EPS Growth
  • COEP N/A
  • SPCB N/A
  • EPS
  • COEP N/A
  • SPCB 1.02
  • Revenue
  • COEP N/A
  • SPCB $26,843,000.00
  • Revenue This Year
  • COEP N/A
  • SPCB $6.72
  • Revenue Next Year
  • COEP N/A
  • SPCB $15.83
  • P/E Ratio
  • COEP N/A
  • SPCB $13.15
  • Revenue Growth
  • COEP N/A
  • SPCB 5.23
  • 52 Week Low
  • COEP $2.31
  • SPCB $2.55
  • 52 Week High
  • COEP $13.58
  • SPCB $13.49
  • Technical
  • Relative Strength Index (RSI)
  • COEP 75.88
  • SPCB 78.09
  • Support Level
  • COEP $6.22
  • SPCB $7.84
  • Resistance Level
  • COEP $10.00
  • SPCB $10.05
  • Average True Range (ATR)
  • COEP 1.79
  • SPCB 2.29
  • MACD
  • COEP 0.43
  • SPCB 0.54
  • Stochastic Oscillator
  • COEP 90.51
  • SPCB 99.29

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

Share on Social Networks: